A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer

Alberto Chiappori, Tatjana Kolevska, David R. Spigel, Steven Hager, Mark U. Rarick, Shirish M. Gadgeel, Normand Blais, Joachim von Pawel, L. Hart, Martin Reck,

Annals of Oncology · 2014 · 178 citations · 19 references

DOIFull text

Open access

Concepts

References

19